ArticleMolecular medicine (Cambridge, Mass.)2025

Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancer.

Ana Lameirinhas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.